Carmell Therapeutics Corp WT CTCXW

Valuation

Market cap

—

Revenue TTM

$0

Net income TTM

$-15,450,000

P/E (trailing)

—

P/E (forward)

—

Profit margin

—

Debt to equity

—

Trading

Volume

16,100

Avg volume

14,636

Day's range

$0.09 – $0.13

Shares out

—

Stochastic %K

44%

Beta

—

Analysts

—

Price target

—

Price